1-4 of 4
Joanne C Ewing, PhD BMBS, BSc, FRPATH,
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Interim Analysis of the Myeloproliferative Disorders Research Consortium (MPD-RC) 112 Global Phase III Trial of Front Line Pegylated Interferon Alpha-2a Vs. Hydroxyurea in High Risk Polycythemia Vera and Essential Thrombocythemia

John O. Mascarenhas, MD MS, Josef T. Prchal, MD, Alessandro Rambaldi, MD, Ruben A. Mesa, MD, Dmitriy Berenzon, MD, Abdulraheem Yacoub, MD, Claire N. Harrison, DM, FRCP, FRCPath, Mary Frances McMullin, MD, Alessandro M. Vannucchi, MD PhD, Joanne C Ewing, PhD BMBS, BSc, FRPATH,, Casey L O'Connell, MD, Jean-Jacques Kiladjian, MD PhD, Adam Mead, MD PhD, Elliott F. Winton, MD, David S. Leibowitz, MD, Valerio De Stefano, Murat O. Arcasoy, MD, Craig M. Kessler, MD, Rosalind Catchatorian, Damiano Rondelli, MD, Richard T. Silver, MD, Ellen K. Ritchie, MD, Arnon Nagler, Marina Kremyanskaya, MD PhD, Richard F. Schlenk, MD, Rona Singer Weinberg, PhD, Mohamed E Salama, MD, Gianni Tognoni, Giuseppe Prosperini, Alessandra Di Lelio, Eliseo Serone, Lorenzo Marfisi, Jill Kleczko, Heidi E. Kosiorek, MS, Tiziano Barbui, MD, Amylou C. Dueck, PhD, Ronald Hoffman, MD
Journal: Blood
Blood (2016) 128 (22): 479.
https://doi.org/10.1182/blood.V128.22.479.479
Published: 2016
Journal Articles

Impact on MPN Symptoms and Quality of Life of Front Line Pegylated Interferon Alpha-2a Vs. Hydroxyurea in High Risk Polycythemia Vera and Essential Thrombocythemia: Interim Analysis Results of Myeloproliferative Disorders Research Consortium (MPD-RC) 112 Global Phase III Trial

Ruben A. Mesa, MD, Ronald Hoffman, MD, Heidi E. Kosiorek, MS, Josef T. Prchal, MD, Claire N. Harrison, DM, FRCP, FRCPath, Mary Frances McMullin, MD, Abdulraheem Yacoub, MD, Alessandro Rambaldi, MD, Dmitriy Berenzon, MD, Alessandro M. Vannucchi, MD PhD, Joanne C Ewing, PhD BMBS, BSc, FRPATH,, Casey L O'Connell, MD, Jean-Jacques Kiladjian, MD PhD, Adam Mead, MD PhD, Elliott F. Winton, MD, David S. Leibowitz, MD, Valerio De Stefano, MD, Murat O. Arcasoy, MD, Craig M. Kessler, MD, Rosalind Catchatorian, Damiano Rondelli, MD, Richard T. Silver, MD, Ellen K. Ritchie, MD, Arnon Nagler, Marina Kremyanskaya, MD PhD, Richard F. Schlenk, MD, Rona Singer Weinberg, PhD, Mohamed E Salama, MD, Gianni Tognoni, Giuseppe Prosperini, Alessandra Di Lelio, Eliseo Serone, Lorenzo Marfisi, Alicia Orellana, MD, Tiziano Barbui, MD, Amylou C. Dueck, PhD, John O. Mascarenhas, MD MS
Journal: Blood
Blood (2016) 128 (22): 4271.
https://doi.org/10.1182/blood.V128.22.4271.4271
Published: 2016
Journal Articles

Myeloproliferative Neoplasm Quality of Life (MPN-QOL) Study Group: Interim Results from the MPN Experimental Assessment of Symptoms By Utilizing Repetitive Evaluation (MEASURE) Trial

Allison H Scotch, MD MPH, Robyn M. Scherber, MD MPH, Nan Zhang, MS, Heidi E. Kosiorek, MS, Amylou C. Dueck, PhD, Holly Geyer, MD, Veena Fauble, MD, Alessandro M. Vannucchi, MD PhD, Ana Kerguelen Fuentes, Christen Lykkegaard Andersen, MD PhD, Elisabeth Ejerblad, MD, Gunnar Birgegard, MD PhD, Peter L. Johansson, MD PhD, Bjorn Andreasson, David M. Ross, MBBS, PhD FRACP, FRCPA, Federico Sackmann, MD, Jean-Loup Demory, MD, Constantine S. Tam, Jan J. Michiels, PhD, Deepti Radia, MBBS, MRCPI, FRCPath MSc, MD, Mohan Mahalakshmi, MD, Daniel Jennings, Joanne C Ewing, PhD BMBS, BSc, FRPATH,, Frances Wadelin, MD, Robert N Lown, MBBS, MDRes), MRCP, FRCPath, Victoria Drew, John Hudson, Mary Frances McMullin, MD, Wunna Swe, Jonathan O. Cullis, MD MB, BS, MA, FRCP, FRCPath, Nigel Sargant, BSc, FRPATH, MRCP,, Paul Moreton, MD MRCP, MRCPath, Mari Frances Kilner, MBBS,MRCP,FRCPath, Catherine Cargo, MB, FRCPath, Mallika Sekhar, MBBS,MDFRCPath,FRCP, Satareh Shekouhi, Ruben A. Mesa, MD
Journal: Blood
Blood (2016) 128 (22): 5479.
https://doi.org/10.1182/blood.V128.22.5479.5479
Published: 2016
Journal Articles

Correlation Between Treatment Outcomes, Baseline Characteristics and Molecular Responses in the Majic Study Which Compared Ruxolitinib to Best Available Therapy in Essential Thrombocythemia

Claire N. Harrison, DM, FRCP, FRCPath, Adam Mead, MD PhD, Sonia Fox, Anesh Panchal, BSc, MSc, Christina Yap, BSc, MSc, PhD, Aimee E Houlton, BSc, MSc, Samah Aliman, Joanne C Ewing, PhD BMBS, BSc, FRPATH,, Marion Wood, FRCP, FRCPath, Frederick Chen, MBBS, PhD FRCPath, Jason Coppell, Nicki Panoskaltsis, MD PhD, Steven Knapper, Sahra Ali, FRCPath, Angela Hamblin, MDPhD, Robyn M. Scherber, MD MPH, Holly Geyer, MD, Allison H Scotch, MD MPH, Amylou Constance Dueck, PhD, Nicholas CP Cross, PhD, Ruben A. Mesa, MD, Mary Frances McMullin, MD
Journal: Blood
Blood (2016) 128 (22): 1929.
https://doi.org/10.1182/blood.V128.22.1929.1929
Published: 2016